Zelira Therapeutics Announces Licensing Agreement with Alternative Solutions to Expand HOPE™ Distribution to Include Washington DC

Zelira Therapeutics Ltd (ASX:ZLD, OTCQB:ZLDAF), a leader in cannabis research and the development of clinically validated cannabis medicines, just announced its newest licensing agreement for its HOPE™ line of products, Zelira’s top-selling treatment developed for autism patients. Under the agreement with Alternative Solutions, a licensed grower, manufacturer and distributor of medical cannabis products in the District of Columbia (Washington DC), HOPE™ will be produced and distributed throughout the legal DC medical cannabis market beginning in Q2 2021.

“We are thrilled to have Alternative Solutions as a partner to launch HOPE™ in the nation’s capital,” says Dr. Oludare Odumosu, CEO & Managing Director USA for Zelira. “They are a leader in the DC medical cannabis market, and this partnership will allow legal access of HOPE™ to more patients across the country than ever before.”

Odumosu notes that this agreement with Alternative Solutions signifies HOPE’s largest expansion to date; because Washington DC has reciprocity with 32 other states in the US with approved medical cannabis programs, patients registered in those states are able to legally purchase medical cannabis products at an approved dispensary in Washington DC.

HOPE™ was formulated by Zelira Therapeutics and is the brainchild of Erica Daniels, founder of Hope Grows for Autism, a nonprofit aimed at improving the lives of families affected by autism through research, education and advocacy of medical marijuana. HOPE™ is currently available in the United States in Pennsylvania, through an exclusive license agreement with Ilera Healthcare, and in Louisiana, through an agreement with Advanced Biomedics LLC.

Leave a Reply

Your email address will not be published. Required fields are marked *

Don't Miss This Week's Groundbreaking News

Join the thousands of subscribers who stay informed with GMR's exclusive news briefs delivered directly to your inbox every Friday afternoon.

We respect your privacy. See our privacy policy.


About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets

@GreenMarketRpt – 5 hours

15 Million Women Have Bought In 2021 $KERN

@GreenMarketRpt – 1 day

$SMG segment Hawthorne driving revenue growth

@GreenMarketRpt – 1 day

$JAZZ has big plans for drug . Helping more children with other forms of #epilepsy…

Back to Top